ImmuCell Corp Sustainability Reports
ImmuCell Corporation develops, manufactures, and commercializes animal health biologics for the dairy and beef industries. Its primary product line, First Defense, provides immediate immunity to newborn calves against the primary causes of scours.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493003G4YVJPVDW6U67
FIGI: BBG001S5S3P1
9 reports from 2005 to 2024
